nad has been researched along with deoxycytidine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komatsu, Y; Tanaka, K | 1 |
| Henle, ES; Linn, S; Luo, Y | 1 |
| Chen, D; Di Cresce, C; Ferguson, PJ; Figueredo, R; Koropatnick, J; Maleki Vareki, S; Min, W; Pampillo, M; Rytelewski, M; Vincent, M; Zheng, X | 1 |
| Chiao, PJ; Fan, XQ; Ju, HQ; Li, H; Lu, YX; Mo, HY; Sheng, H; Tian, T; Xu, RH; Zhou, HJ; Zhuang, ZN | 1 |
4 other study(ies) available for nad and deoxycytidine
| Article | Year |
|---|---|
Deoxycytidine uptake by isolated membrane vesicles from Escherichia coli K 12.
Topics: Ascorbic Acid; Azides; Biological Transport; Carbon Isotopes; Cell Fractionation; Cell Membrane; Chloromercuribenzoates; Deoxycytidine; Deoxyribonucleosides; Electron Transport; Escherichia coli; Iodoacetates; Lactates; Mutation; NAD; Nucleosides; Organoids; Proline; Succinates; Thymidine; Time Factors; Uridine | 1973 |
Oxidative damage to DNA constituents by iron-mediated fenton reactions. The deoxycytidine family.
Topics: Chromatography, High Pressure Liquid; Deoxycytidine; DNA Damage; Iron; Magnetic Resonance Spectroscopy; NAD; Oxidative Stress; Spectrometry, Mass, Fast Atom Bombardment; Spectrophotometry, Ultraviolet | 1996 |
IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells.
Topics: Acrylamides; Animals; BRCA2 Protein; Cell Line, Tumor; Clone Cells; Deoxycytidine; DNA Repair; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Induction; Floxuridine; Gemcitabine; Gene Knockdown Techniques; Humans; Hydroxylamines; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice, SCID; NAD; Pemetrexed; Piperidines; RNA, Small Interfering; Thymidylate Synthase; Xenograft Model Antitumor Assays | 2015 |
Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer.
Topics: 3' Untranslated Regions; Acrylamides; Animals; Antimetabolites, Antineoplastic; Binding Sites; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cytokines; Deoxycytidine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Gemcitabine; Glycolysis; Humans; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; MicroRNAs; NAD; Nicotinamide Phosphoribosyltransferase; Pancreatic Neoplasms; Piperidines; RNA Interference; Time Factors; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |